Obesity  >>  Adlyxin (lixisenatide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adlyxin (lixisenatide) / Sanofi
NCT02274740 / 2014-002263-15: Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients

Terminated
2
2
Europe
LIXISENATIDE AVE0010, metformin
Sanofi
Type II Diabetes Mellitus
08/15
08/15

Download Options